NEW YORK — The Senate on Wednesday confirmed Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention, placing her in charge of a public health agency beleaguered by political meddling and low morale.
Schwartz was confirmed in a 51-44 vote. The 54-year-old becomes the 22nd leader of the Atlanta-based CDC, which is charged with protecting Americans from preventable health threats, and the agency’s first confirmed director in nearly a year. Her resume includes medical and law degrees, a stint as deputy surgeon general, and a leadership position at the U.S. Coast Guard.
Schwartz’s nomination appeared to be on shaky ground after a hearing before the Senate Health, Education, Labor and Pensions Committee last month. The chairman, Sen. Bill Cassidy, R-La., and others questioned whether she would be willing to stand up to Republican President Donald Trump’s health secretary, Robert F. Kennedy Jr., if he ordered CDC to do something unsupported by science and good public health practice.
But weeks later, Cassidy said he had spoken with Schwartz after that hearing and with others who knew her, and said he had gained confidence in her.
U.S. Department of Health and Human Services officials did not immediately respond to questions about when Schwartz will start the job or her salary.
The CDC has been in turmoil since Trump returned to office last year.
Largely due to layoffs and resignations, the agency has lost 3,000-plus employees, more than one-quarter of its workforce. Morale has plummeted as a succession of mostly temporary leaders has come and gone. The front office has been staffed by political appointees with little or no training in medicine or public health.
“Now, Dr. Schwartz needs to prove that her leadership will serve science and not the whims of politicians. CDC needs a Director who will protect public health workers, defend evidence-based guidance, and refuse any directive that would undermine public safety,” said the National Public Health Coalition, an organization of former and current CDC workers, in a statement Wednesday.
When Schwartz was nominated in April, public health experts were cautiously optimistic, citing her background. They also noted that Schwartz was the choice of Trump and not Kennedy, who is a leading voice in the anti-vaccine movement before he was tapped to oversee the CDC and other federal health agencies.
Schwartz was the third Trump nominee for CDC director in the past 18 months.
The first was a former Florida congressman, Dr. David Weldon. His Senate hearing in March 2025 was canceled an hour before it was to begin. Weldon said at the time that he had been told not enough senators were willing to vote for him.
The White House then moved on to Susan Monarez, who had been serving as the CDC’s acting director. Monarez was confirmed by the Senate, but ousted from the job in less than a month. Trump administration officials said she was not aligned with the president’s agenda, so they terminated her.
Since then, there have been a series of HHS officials as acting CDC directors.
“With all the turmoil of the past two years, the CDC desperately needs stability, experienced leadership and a steadfast commitment to science,” said Dr. Georges Benjamin of the American Public Health Association, in a statement Wednesday.
The CDC position was one of several leadership vacancies among federal health agencies, including the U.S. surgeon general and the commissioner of the Food and Drug Administration.
